Business & Finance
Wed, March 16, 2011Tue, March 15, 2011Mon, March 14, 2011Sun, March 13, 2011Sat, March 12, 2011Fri, March 11, 2011Thu, March 10, 2011Wed, March 9, 2011Tue, March 8, 2011Mon, March 7, 2011Sun, March 6, 2011Sat, March 5, 2011Fri, March 4, 2011JMP Group Announces Addition of Margery Fischbein to Healthcare Investment Banking Group
//business-finance.news-articles.net/content/201 .. bein-to-healthcare-investment-banking-group.html
Published in Business and Finance on Thursday, March 10th 2011 at 5:11 GMT by Market Wire🞛 This publication is a summary or evaluation of another publication
SAN FRANCISCO--([ BUSINESS WIRE ])--JMP Group Inc. (NYSE:JMP), an investment banking and alternative asset management firm, announced today that Margery Fischbein has joined JMP Securities, JMP Groupa™s broker-dealer subsidiary, as a managing director in the healthcare investment banking group. Ms. Fischbein is based in the firma™s New York office.
"Margery will be a key member of JMP Securitiesa™ healthcare investment banking effort"
aMargery will be a key member of JMP Securitiesa™ healthcare investment banking effort,a said Kent Ledbetter, director of investment banking at JMP Securities. aShe comes to us with an impressive background in life sciences M&A, with prior roles in investment banking, venture capital and the biotech industry. While Margery has served in a senior capacity at various bulge bracket firms, she was most recently a managing director at a successful M&A boutique and brings an entrepreneurial skill set that is a tremendous fit for JMP. We are very pleased to have Margery join our firm.a
Prior to joining JMP Securities, Ms. Fischbein was a managing director at Beal Advisors, a boutique investment banking firm focused on the life sciences industry, where she specialized in mergers and acquisitions and private placements. She was previously an executive vice president and head of mergers and acquisitions at Paramount BioSciences, a biotechnology venture capital firm. Ms. Fischbein has also served as vice president of business development at publicly traded Human Genome Sciences, Inc. and ImClone Systems Incorporated. Prior to entering the biotechnology industry, she spent seven years as an investment banker at Citigroup, where she was a managing director focused on the pharmaceuticals and chemicals industries. Earlier, she served as a managing director in mergers and acquisitions at Chase Manhattan Bank and as a senior vice president in investment banking at Lehman Brothers. Ms. Fischbein received an MBA from Harvard Business School and a BA from Harvard University.
About JMP Group
JMP Group Inc. is a full-service investment banking and asset management firm that provides investment banking, sales and trading, and equity research services to corporate and institutional clients and alternative asset management products to institutional and high-net-worth investors. JMP Group operates through three subsidiaries: JMP Securities, Harvest Capital Strategies and JMP Credit Advisors. For more information, visit [ www.jmpg.com ].
